| Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score A Zhan, S Mohan, C Tarolli, RB Schneider, JL Adams, S Sharma, ... JAMA neurology 75 (7), 876-880, 2018 | 378 | 2018 |
| Risk of COVID-19-related bullying, harassment and stigma among healthcare workers: an analytical cross-sectional global study TD Dye, L Alcantara, S Siddiqi, M Barbosu, S Sharma, T Panko, ... BMJ open 10 (12), e046620, 2020 | 212 | 2020 |
| Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial MA Schwarzschild, A Ascherio, MF Beal, ME Cudkowicz, GC Curhan, ... JAMA neurology 71 (2), 141-150, 2014 | 212 | 2014 |
| National randomized controlled trial of virtual house calls for Parkinson disease CA Beck, DB Beran, KM Biglan, CM Boyd, ER Dorsey, PN Schmidt, ... Neurology 89 (11), 1152-1161, 2017 | 210 | 2017 |
| Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ... Jama 313 (6), 584-593, 2015 | 176 | 2015 |
| Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial L Neurol Lancet Neurol 14 (8), 795-803, 2015 | 129 | 2015 |
| Isradipine versus placebo in early Parkinson disease: a randomized trial Parkinson Study Group STEADY-PD III Investigators* Annals of internal medicine 172 (9), 591-598, 2020 | 106 | 2020 |
| Association between change in body mass index, unified Parkinson’s disease rating scale scores, and survival among persons with Parkinson disease: secondary analysis of … AMA Wills, A Pérez, J Wang, X Su, J Morgan, SS Rajan, MA Leehey, ... JAMA neurology 73 (3), 321-328, 2016 | 91 | 2016 |
| Contraceptive knowledge, attitude and practice among eligible couples of rural Haryana N Saluja, S Sharma, S Choudhary, D Gaur, S Pandey Internet J Health 12 (1), 25-9, 2011 | 85 | 2011 |
| Caffeine and Progression of Parkinson’s disease: A deleterious interaction with creatine. Clinical Neuropharmacology 38 (5), 163-169, 2015 | 70* | 2015 |
| Multiple wearable sensors in Parkinson and Huntington disease individuals: a pilot study in clinic and at home JL Adams, K Dinesh, M Xiong, CG Tarolli, S Sharma, N Sheth, ... Digital Biomarkers 1 (1), 52-63, 2017 | 67 | 2017 |
| National randomized controlled trial of virtual house calls for people with Parkinson's disease: interest and barriers ER Dorsey, MA Achey, CA Beck, DB Beran, KM Biglan, CM Boyd, ... Telemedicine and e-Health 22 (7), 590-598, 2016 | 60 | 2016 |
| Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease O Klepitskaya, Y Liu, S Sharma, SH Sillau, J Tsai, AS Walters Neurology 91 (11), e1013-e1021, 2018 | 44 | 2018 |
| Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores M • Leehey, S Luo, S Sharma, AM Wills, JL Bainbridge, PS Wong, ... Neurology, 2017 | 38 | 2017 |
| Malignant melanoma in early‐treated Parkinson's disease: The NET‐PD trial R Constantinescu, J Elm, P Auinger, S Sharma, EF Augustine, L Khadim, ... Movement Disorders 29 (2), 263-265, 2014 | 37 | 2014 |
| A real-world study of wearable sensors in Parkinson’s disease JL Adams, K Dinesh, CW Snyder, M Xiong, CG Tarolli, S Sharma, ... npj Parkinson's Disease 7 (1), 106, 2021 | 34 | 2021 |
| Caffeine, creatine, GRIN2A and Parkinson's disease progression DK Simon, C Wu, BC Tilley, K Lohmann, C Klein, H Payami, AM Wills, ... Journal of the neurological sciences 375, 355-359, 2017 | 33 | 2017 |
| Critical medical ecology and SARS-COV-2 in the urban environment: a pragmatic, dynamic approach to explaining and planning for research and practice T De Ver Dye, E Muir, L Farovitch, S Siddiqi, S Sharma Infectious Diseases of Poverty 9 (03), 90-96, 2020 | 31 | 2020 |
| A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned R Pfeiffer, PS Group Parkinsonism and Related Disorders 37 (2017), 101-105, 2017 | 30 | 2017 |
| Peripheral biomarkers of Parkinson’s disease progression and pioglitazone effects DK Simon, T Simuni, J Elm, J Clark-Matott, AK Graebner, L Baker, ... Journal of Parkinson's disease 5 (4), 731-736, 2015 | 30 | 2015 |
Christopher G TarolliUniversity of Rochester Medical Center在 urmc.rochester.edu 的电子邮件经过验证
